Dr. Cooke has over thirty years of experience in the vaccine industry. He was previously CEO of NovaDigm Therapeutics, CEO of Mojave Therapeutics, COO at AVANT Immunotherapeutics and SVP at Ology Bioservices. Prior to his leadership roles in the biotechnology industry, he held several positions at Merck establishing a global vaccine-focused marketing and sales organization. Dr. Cooke was the biotechnology industry representative to the U.S. National Vaccine Advisory Committee during 2015-2023. He was on the Advisory Board of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and was an observer on the WHO Technical Advisory Group on Vaccines and Antimicrobial Resistance. He was previously Co-Chair of the BIO Vaccine Policy Advisory Committee. Dr. Cooke has a Ph.D. in bio-organic chemistry and an M.B.A. from Columbia University and a B.S. from Saint Joseph’s University.